John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIAB
701
DELISTED
Viacom Inc. Class B
VIAB
| $4.49M | 0.02% |
109,100
+102,510
| +1,556% | +$4.81M |
|
|
GHDX
702
DELISTED
Genomic Health, Inc.
GHDX
| $4.48M | 0.02% |
127,369
+100,236
| +369% | +$2.68M |
|
703
FNB Corp
FNB
$6.61B
| $4.47M | 0.02% |
335,225
-320,748
| -49% | -$4.38M |
|
704
CALL
Netflix
NFLX
$334B
| $4.46M | 0.02% |
390,000
+50,000
| +15% | +$571K |
|
705
Sarepta Therapeutics
SRPT
$1.93B
| $4.46M | 0.02% |
115,518
+26,251
| +29% | +$851K |
|
706
PUT
Altria Group
MO
$113B
| $4.42M | 0.02% |
+76,000
| New | +$4.4M |
|
707
Hope Bancorp
HOPE
$1.79B
| $4.42M | 0.02% |
+256,525
| New | +$4.4M |
|
|
MORE
708
DELISTED
Monogram Residential Trust, Inc.
MORE
| $4.42M | 0.02% |
+452,348
| New | +$4.46M |
|
|
MFA
709
MFA Financial
MFA
$906M
| $4.41M | 0.02% |
167,121
+112,953
| +209% | +$3.12M |
|
710
CAE Inc
CAE
$7.9B
| $4.4M | 0.02% |
396,600
+41,749
| +12% | +$468K |
|
711
Oceaneering
OII
$5.08B
| $4.38M | 0.02% |
116,764
+6,335
| +6% | +$271K |
|
712
Cavco Industries
CVCO
$4.5B
| $4.38M | 0.02% |
52,549
+33,190
| +171% | +$2.82M |
|
713
Expeditors International
EXPD
$24.5B
| $4.37M | 0.02% |
96,816
+48,116
| +99% | +$2.33M |
|
714
Cameco
CCJ
$45B
| $4.37M | 0.02% |
+353,983
| New | +$4.54M |
|
|
BLD
715
DELISTED
TopBuild
BLD
| $4.34M | 0.02% |
141,145
+73,945
| +110% | +$2.22M |
|
716
PUT
Johnson & Johnson
JNJ
$653B
| $4.31M | 0.02% |
42,000
-40,000
| -49% | -$4.02M |
|
|
QIHU
717
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $4.31M | 0.02% |
+59,200
| New | +$3.73M |
|
|
CMBT
718
CMB.TECH NV
CMBT
$5.25B
| $4.31M | 0.02% |
+314,294
| New | +$4.45M |
|
719
PUT
Walt Disney
DIS
$191B
| $4.31M | 0.02% |
41,000
-12,000
| -23% | -$1.34M |
|
|
WSTC
720
DELISTED
West Corporation
WSTC
| $4.31M | 0.02% |
199,680
-86,017
| -30% | -$2.06M |
|
721
Hawaiian Electric Industries
HE
$1.97B
| $4.31M | 0.02% |
148,726
-35,058
| -19% | -$1.01M |
|
|
SHOR
722
DELISTED
ShoreTel, Inc.
SHOR
| $4.27M | 0.02% |
482,871
+262,470
| +119% | +$2.44M |
|
723
PUT
IBM
IBM
$219B
| $4.27M | 0.02% |
32,426
+30,334
| +1,450% | +$4.08M |
|
|
JCP
724
DELISTED
J.C. Penney Company, Inc.
JCP
| $4.26M | 0.02% |
639,639
-983,556
| -61% | -$8.21M |
|
|
ARGO
725
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $4.23M | 0.02% |
89,403
| – | – |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.